US Patent 9079928 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

U.S. Patents

PharmaCompass Sponsored Ads

Post An Enquiry

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

PharmaCompass Sponsored Ads

Post An Enquiry

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Xls

CATEGORY PAGE

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3COMMAVE THERAP

filter Patent Number Reset all filters

3 All

01 39079928

API Patent Reset all filters

3 All

01 3Blank

filter FDF Patent Reset all filters

3 All

01 3Y

filter Expiration Date Reset all filters

3 All

01 32032-07-27

01

COMMAVE THERAP

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

BPI West

Not Confirmed

COMMAVE THERAP

Country

BPI West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-07-27

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 9079928

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212994

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-07-27

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

COMMAVE THERAP

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

BPI West

Not Confirmed

COMMAVE THERAP

Country

BPI West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-07-27

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 9079928

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212994

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-07-27

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

COMMAVE THERAP

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

BPI West

Not Confirmed

COMMAVE THERAP

Country

BPI West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-07-27

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 9079928

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212994

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-07-27

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.